SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-012445
Filing Date
2022-05-09
Accepted
2022-05-09 08:02:47
Documents
77
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1488091
2 ex10-1.htm EX-10.1 28439
3 ex31-1.htm EX-31.1 18832
4 ex31-2.htm EX-31.2 19228
5 ex32-1.htm EX-32.1 6112
6 ex32-2.htm EX-32.2 5592
7 form10-q_001.jpg GRAPHIC 45045
8 form10-q_002.jpg GRAPHIC 49887
9 form10-q_003.jpg GRAPHIC 28551
10 form10-q_004.jpg GRAPHIC 25362
11 form10-q_010.jpg GRAPHIC 30551
12 form10-q_005.jpg GRAPHIC 32236
13 fom10-q_006.jpg GRAPHIC 69278
14 fom10-q_007.jpg GRAPHIC 52745
15 fom10-q_008.jpg GRAPHIC 86406
  Complete submission text file 0001493152-22-012445.txt   7070424

Data Files

Seq Description Document Type Size
16 XBRL SCHEMA FILE lpcn-20220331.xsd EX-101.SCH 37362
17 XBRL CALCULATION FILE lpcn-20220331_cal.xml EX-101.CAL 49011
18 XBRL DEFINITION FILE lpcn-20220331_def.xml EX-101.DEF 166100
19 XBRL LABEL FILE lpcn-20220331_lab.xml EX-101.LAB 324283
20 XBRL PRESENTATION FILE lpcn-20220331_pre.xml EX-101.PRE 266105
71 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 967207
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36357 | Film No.: 22903311
SIC: 2834 Pharmaceutical Preparations